During the year the industry saw continued consolidation, the end of a key advisory body, the rise in DTC testing and advanced diagnostics, and another stab at PAMA reform.
CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely ...
Launched less than three years ago, the system may be changing how point-of-care tests are used in doctor's offices and emergency rooms.
NEW YORK – An investor holding stake in OraSure Technologies, Altai Capital Management, announced Wednesday that it intends to nominate two candidates to OraSure's board of directors, hinting at a ...
Launched less than three years ago, the system may be changing how point-of-care tests are used in doctor's offices and emergency rooms.
The goal of the proposal is to "streamline and future-proof" the IVDR, particularly to relieve the burden on small- and medium-sized enterprises.
Protavio is leading the development of the IVD-grade test kit, while Repado is developing the test's analysis software.
Top Five Articles on 360Dx Last Week: Roche Vaginitis Test; FDA Reclassification of CDx Assays; More
Last week, readers were most interested in a story about a PCR test from Roche for vaginitis getting CE marking.
The man unlawfully billed Medicare for hundreds of millions of dollars as part of a cancer genetics and cardiovascular genetics testing scheme, according to the DOJ.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results